Lv62
2910 积分 2024-04-17 加入
Pharmacokinetic models for first-in-human dose selection of immune-activating products in oncology
6天前
已完结
Pharmacokinetic considerations for angiogenesis inhibitors used to treat hepatocellular carcinoma: an overview
15天前
已完结
A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors
17天前
已完结
Payload‐Based Clinical Pharmacology Review of Approved Antibody–Drug Conjugates: Commonalities and Considerations for Streamlined Development
20天前
已完结
The Future of Clinical Translational Pharmacology
1个月前
已完结
TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for De Novo Modeling and Simulation From Experimental Data
1个月前
已完结
Essentials in Clinical Pharmacokinetics: Concepts, Dose Optimization, and Biologics
1个月前
已关闭
Advanced Pharmacokinetics and Pharmacodynamics: Lecture Notes and Self-study Guide
1个月前
已关闭
Distribution of UGT1A1 (TA) polymorphisms in Caucasian and Asian subjects
1个月前
已关闭
The role of zongertinib, a highly selective tyrosine kinase inhibitor, in targeting HER2 -mutant NSCLC: a bench-to-bedside review
2个月前
已完结
皖公网安备34019202002308
